IP Verse

Stable Anti-Ifnar1 Formulation

Patent No. EP3769781 (titled "Stable Anti-Ifnar1 Formulation") was filed by Astrazeneca on Aug 18, 2016. The application was issued on Apr 19, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDJan 18, 2024MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3769781

ASTRAZENECA
Application Number
EP20174805A
Filing Date
Aug 18, 2016
Status
Granted And Under Opposition
Mar 17, 2023
Publication Date
Apr 19, 2023
External Links
Slate, Register , Google Patents